Product Information
CEFTRIAXONE 2 GM VIAL is a generic product labeled by Hospira Inc., priced at $2.5582 per EA under NDC 00409733520. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
2 g/1
Manufacturer
Hospira Inc.NDC
00409733520
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
CEFTRIAXONE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA065169On Market Since
5/9/2005
Pharmacological Classes
Price Statistics
The NADAC for CEFTRIAXONE 2 GM VIAL has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 14.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5582 per EA |
|---|---|
| All-time high | $3.0835 (Sep 11, 2024) |
| All-time low | $2.2684 (Oct 22, 2025) |
| 52-week high | $2.6163 |
| 52-week low | $2.2684 |
| Median price | $2.5582 |
| Average price | $2.6237 |
| Largest weekly change | -11.8% (May 22, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFTRIAXONE 2 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFTRIAXONE 2 GM VIAL, manufactured by Hospira Inc., is $2.5582 per EA (NDC 00409733520), effective Jun 24, 2026.
How has the price of CEFTRIAXONE 2 GM VIAL changed over time?
Over the history we have for it, the NADAC for CEFTRIAXONE 2 GM VIAL has declined 14.1%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CEFTRIAXONE 2 GM VIAL?
Since Apr 17, 2024, the NADAC for CEFTRIAXONE 2 GM VIAL has ranged from a low of $2.2684 (Oct 22, 2025) to a high of $3.0835 (Sep 11, 2024), with a median of $2.5582 per EA.
Are there cheaper alternatives to CEFTRIAXONE 2 GM VIAL?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CEFTRIAXONE 2 GM VIAL, but none are currently priced below it.
Who manufactures CEFTRIAXONE 2 GM VIAL?
CEFTRIAXONE 2 GM VIAL (NDC 00409733520) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification